NCT Number: NCT02489643
Individualized Medical Training and Calcipotriol and Betamethasone Dipropionate Gel in Plaque Psoriasis
The aim of the study will be to evaluate the impact of this individualized practical training on efficacy (evaluated by Psoriasis Area and Severity Index (PASI) and Body Surface Area (BSA) score performed by a physician blinded to the study groups) and adherence (calculated as days wherein gel was applied and as BSA/weight of gel applied rate) to a 4 week long treatment with dovobet gel. On the other hand, the investigators will evaluate in both groups as demographic (as sex, age, job,..) or disease (as severity, duration, impact of quality of life,..) characteristics influence the adherence to the treatment.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Diagnosis of psoriasis will be maid mainly on clinical findings. If doubts, a skin sample will be obtained and evaluated by histopathological examination.
Exclusion criteria
- Patients with palmoplantar, scalp, inverse, erythrodermic, guttate, pustular psoriasis will be excluded.
Treatment and study plan
Primary outcomes
-
Efficacy as measured by PASI improvement
Time frame: 1 month
-
Efficacy as measured by BSA improvement
Time frame: 1 month
Secondary outcomes
-
Adherence as measured by days wherein gel was applied
Time frame: 1 month
-
Adherence as measured by BSA/weight of gel applied rate
Time frame: 1 month
Sponsors and collaborators
Lead sponsor
Catholic University of the Sacred Heart
Other
Registry information
Official study title
Role of an Individualized Medical Training in Improving Efficacy and Adherence to a 4-week Treatment With Calcipotriol and Betamethasone Dipropionate Gel for Mild-to-moderate Plaque Psoriasis
Important dates
- Study start
- 2014
- Primary completion
- 2015
- First posted
- Jul 3, 2015
- Registry last updated
- Jul 7, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Anti-Inflammatory Effects of Time-Restricted Feeding
NCT04728165
Psoriasis, Skin Diseases
Bethesda, Maryland, United States
View Trial DetailsThe Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)
NCT01778569
Cardiovascular Disease, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsChinese Medicine for Patients With Psoriasis
NCT05295979
Psoriasis, Skin Diseases
Hong Kong
View Trial DetailsHPP737 in Adult Patients With Plaque Psoriasis
NCT07712731
Psoriasis, Skin Diseases
Baotou, China
View Trial Details